RT Journal Article
SR Electronic
T1 Letter to the editor: radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e003044
DO 10.1136/jitc-2021-003044
VO 9
IS 7
A1 Mateus Trinconi Cunha
A1 Vinicius Jardim Carvalho
A1 Rafael Maffei Loureiro
A1 Carlos Eduardo Brantis-de-Carvalho
A1 Murilo Bicudo Cintra
A1 Gilberto de Castro Junior
YR 2021
UL http://jitc.bmj.com/content/9/7/e003044.abstract
AB A commentary on the original research article: ‘Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers’. Of note, the predictor selection process, the cross-validation method, along with the lack of final testing of the developed model with a separated data set may mask overfitting, overestimating performance metrics.